GB1022966A - New sulphonamides and process for their manufacture - Google Patents
New sulphonamides and process for their manufactureInfo
- Publication number
- GB1022966A GB1022966A GB1076564A GB1076564A GB1022966A GB 1022966 A GB1022966 A GB 1022966A GB 1076564 A GB1076564 A GB 1076564A GB 1076564 A GB1076564 A GB 1076564A GB 1022966 A GB1022966 A GB 1022966A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- halogen atom
- amino
- converting
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises sulpha-pyrimidines of the formula <FORM:1022966/C2/1> wherein one of the symbols R1 and R2 represents a lower alkoxy-lower alkyl group (the word "lower" indicating a group of up to 6 carbon atoms) and the other is a hydrogen or halogen atom or a lower alkyl, lower alkoxy, lower alkoxy lower alkyl or lower alkoxy-lower alkoxy group, R3 is a halogen atom or a lower alkyl or alkoxy group and Z1 is an amino, nitro, azo or acylamino group, N1-acyl derivatives thereof and salts, e.g. alkali-metal and alkaline earth metal salts of the compounds wherein Z1 is an amino group; and processes for their production by reacting a benzenesulphonyl halide, p-substituted by an amino, nitro, azo or acylamino group, with the appropriate 4-aminopyrimidine, or reacting a benzenesulphonamide, p-substituted by an amino, nitro, azo or acylamino group, with a 4-halg or 4-trialkylammonium - substituted pyrimidine and, in either case, in any desired order, converting the p-nitro-, acylamino- or azo-substituent in the resulting compound, if present, to an amino group, by reduction or hydrolysis, splitting any resulting bis-benzenesulphonyl compound by hydrolysis, N1-acylating the product, and converting a resulting free compound into a salt or a resulting salt into a free compound. 2-R1-4-R2-5-R3-6-R7-Pyrimidines used as starting materials, in which R7 is a free hydroxy or amino group, an ammonium group such as a lower trialkylammonium group, or a halogen atom, are made by reacting an amidine R1.C(:NH)NH2 or a salt thereof, with a compound of the formula R8.CO.CH(R3).R9, in which R8 is a lower alkoxyalkyl group or, if R1 is a lower alkoxyalkyl group, R8 may be hydrogen, lower alkyl or etherified hydroxy, and R9 is an esterified carboxyl, thioamide or nitrile group or an oxo derivative thereof such as an enol ether or imine; and if desired, converting any hydroxy group in the 4- or 6-position of the resulting compound into a free amino group, and/or a halogen atom in the 6-position into a free amino group, and/or a halogen atom in the 4-position into a lower alkoxy or lower alkoxy-alkoxy group or replacing the halogen atom in the 4-position by hydrogen and/or converting a halogen atom in the 6-position into an ammonium group. Amidines of the formula R1.C(:NH).NH2 are made by converting a nitrile R1.CN into an imido ether and reacting this with ammonia. Pharmaceutical preparations having antibacterial activity comprise the above sulphanilamides of the invention (Z=NH2) and their physiologically tolerable salts, in admixture or conjunction with a pharmaceutical carrier. The preparations suitably take forms adapted to enteral, parenteral or topical administration, e.g. tablets, dragees, salines, creams, solutions, suspensions or emulsions.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH318363A CH430726A (en) | 1963-03-13 | 1963-03-13 | Process for the production of new sulfonamides |
| CH25264 | 1964-01-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1022966A true GB1022966A (en) | 1966-03-16 |
Family
ID=25684034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1076564A Expired GB1022966A (en) | 1963-03-13 | 1964-03-13 | New sulphonamides and process for their manufacture |
Country Status (2)
| Country | Link |
|---|---|
| BE (1) | BE645062A (en) |
| GB (1) | GB1022966A (en) |
-
1964
- 1964-03-12 BE BE645062A patent/BE645062A/xx unknown
- 1964-03-13 GB GB1076564A patent/GB1022966A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE645062A (en) | 1964-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1133766A (en) | Novel acetals and a process for the manufacture and conversion thereof | |
| GB1327312A (en) | Hererocyclic compounds | |
| GB1293303A (en) | Thiohydantoin derivatives, processes for producing them and compositions containing them | |
| GB1131191A (en) | New imidazole derivatives, their preparation and use | |
| GB1120463A (en) | Derivatives of 1,3-diazafluoranthene-1-oxide | |
| GB1155936A (en) | Novel Sulphonamides and a Process for the Manufacture thereof | |
| GB1496787A (en) | Heteroalkylthioalkyl amidine derivatives | |
| GB1022966A (en) | New sulphonamides and process for their manufacture | |
| ES319653A1 (en) | A procedure for the preparation of imidazole derivatives. (Machine-translation by Google Translate, not legally binding) | |
| GB1429654A (en) | Oxime and hydrazine derivatives of phenylketones and their production | |
| GB1293541A (en) | Folic acid derivatives | |
| GB830916A (en) | Aminoguanidine derivatives and their preparation | |
| GB987438A (en) | N,n-disubstituted-1,3-diamino-propanes and 2-propanols | |
| GB913578A (en) | Preparation of tetracycline and tetracycline-urea compounds | |
| ES245448A1 (en) | Improvements in or relating to novel amidines and the preparation thereof | |
| GB756189A (en) | New pyrimidine derivatives | |
| GB680952A (en) | Improvements in new morphine derivatives and production thereof | |
| GB1384091A (en) | Anti-microbially active diamino-succinic acid and diamino-glutaric acid derivatives | |
| GB1035917A (en) | New sulphonamides and process for preparing same | |
| ES317077A1 (en) | 3-amino-3-hydroxymethylalkynes | |
| GB1199687A (en) | Process for Preparing 1,3-Dimethylol-4,5-Dihydroxy-2-Imidazolidinone | |
| US2554213A (en) | I-pyrazolo | |
| GB933968A (en) | New phthalimide derivatives | |
| GB818724A (en) | Hydantoin derivatives | |
| GB1318859A (en) | Imidazo-4,5-b-pyridine derivatives |